Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preemptive dexketoprofen for prevention of acute post-craniotomy headache
2017-000414-35Phase 4Completed
- Sponsor
- University of Debrecen
- Start
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ketamine + dexmedetomidine in Headache (2 arms), sponsored by University of Debrecen. Primary endpoint: Reduction in acute post-craniotomy headache intensity. Started Mar 2017; status: completed.
02
Drugs
ketamine + dexmedetomidine
03
Conditions
Headache
Beyond the preview
Go deeper on 2017-000414-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000414-35.